Top 10 Cancer Drugs Market | Why Increased Funding From Private & Government Organizations?
According to a new report published by Allied Market Research, titled, " Top 10 Cancer Drugs Market: Opportunity Analysis and Industry Forecast, 2018–2026," The top 10 cancer drugs market accounted for $63,619 million in 2018, and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.
♦ Download Free Sample PDF:
Cancer is a medical condition in which abnormal cells develop and have the potential to invade or spread to other parts of the body. The cancer drug market is expected to show significant growth in the market during the forecast period due to the increase in the number of different types of cancer, increasing popularity of advanced treatments such as antibiotic therapy and goals, the development of research methods and the increase in the geriatric population worldwide.
In addition, increasing R&D activities and availability of anti-cancer drugs are expected to boost the market growth. It is expected that the high power of emerging economies and the number of products produced will provide new opportunities for retailers in the future. On the other hand, high cost associated with new drug development and side effects associated with cancer treatment are expected to restrain the market growth.
Key Market Players -
AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc.
♦ For Purchase Enquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/6225
In the current scope of the study, Europe was the leading revenue contributor to the market in 2018, owing to high adoption rate of cancer drugs. However, Asia-Pacific is expected to grow at the highest CAGR from 2019 to 2026, owing to increase in adoption of advanced therapies, surge in research, development, & innovation activities; and rise in awareness related to different cancers.
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Comments
Post a Comment